BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33535007)

  • 1. A case of Guillain-Barré syndrome related to COVID-19 infection.
    Türk Börü Ü; Köseoğlu Toksoy C; Bölük C; Demirbaş H; Yılmaz AÇ
    Int J Neurosci; 2023 Jan; 133(1):86-88. PubMed ID: 33535007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guillain-Barré Syndrome After COVID-19 Infection in Korea: A Case Series.
    Ryoo N; Son H; Kim JH; Bae DW; An JY
    J Korean Med Sci; 2024 Feb; 39(5):e48. PubMed ID: 38317448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of Guillain-Barré Syndrome Associated With COVID-19.
    Rajdev K; Victor N; Buckholtz ES; Hariharan P; Saeed MA; Hershberger DM; Bista S
    J Investig Med High Impact Case Rep; 2020; 8():2324709620961198. PubMed ID: 32981333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal Guillain-Barre syndrome associated with SARS-CoV-2 infection in a child.
    Akçay N; Menentoğlu ME; Bektaş G; Şevketoğlu E
    J Med Virol; 2021 Sep; 93(9):5599-5602. PubMed ID: 33851741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guillain-Barre syndrome and pulmonary embolism in an adult female with COVID-19 infection in Ghana: A case report.
    Tetteh-Wayoe E; Duodu F; Pekyi-Boateng PK; Agyeman Badu NB; Akpalu A; Adjei P
    Medicine (Baltimore); 2023 May; 102(20):e33754. PubMed ID: 37335689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 44-Year-Old Hispanic Man with Loss of Taste and Bilateral Facial Weakness Diagnosed with Guillain-Barré Syndrome and Bell's Palsy Associated with SARS-CoV-2 Infection Treated with Intravenous Immunoglobulin.
    Khaja M; Gomez GPR; Santana Y; Hernandez N; Haider A; Lara JLP; Elkin R
    Am J Case Rep; 2020 Oct; 21():e927956. PubMed ID: 33128540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS.
    Bellucci M; Germano F; Grisanti S; Castellano C; Tazza F; Mobilia EM; Visigalli D; Novi G; Massa F; Rossi S; Durando P; Cabona C; Schenone A; Franciotta D; Benedetti L
    Front Immunol; 2022; 13():894872. PubMed ID: 35924236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.
    Scheidl E; Canseco DD; Hadji-Naumov A; Bereznai B
    J Peripher Nerv Syst; 2020 Jun; 25(2):204-207. PubMed ID: 32388880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [COVID-19-associated Guillain-Barré syndrome in infectious period: a case report].
    Nishida K; Sakashita K; Uchibori A; Chiba A; Futamura N
    Rinsho Shinkeigaku; 2022 Apr; 62(4):293-297. PubMed ID: 35354729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical cases of Guillain-Barré and Miller-Fisher syndromes linked to COVID-19].
    Jasso-Rangel M; Vargas-Martínez KO; Camacho-Frausto LY; Galindo-Félix A; Román-Esquivel JV; Lara-Ramírez EE
    Rev Med Inst Mex Seguro Soc; 2022 Feb; 60(1):91-95. PubMed ID: 35274917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guillain-Barre syndrome associated to COVID-19 infection: a review of published case reports.
    Zuberbühler P; Conti ME; León-Cejas L; Maximiliano-González F; Bonardo P; Miquelini A; Halfon J; Martínez J; Gutiérrez MV; Reisin R
    Rev Neurol; 2021 Mar; 72(6):203-212. PubMed ID: 33710610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19-associated Guillain-Barré syndrome: The early pandemic experience.
    Caress JB; Castoro RJ; Simmons Z; Scelsa SN; Lewis RA; Ahlawat A; Narayanaswami P
    Muscle Nerve; 2020 Oct; 62(4):485-491. PubMed ID: 32678460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guillain-Barré Syndrome Presenting as Facial Diplegia after COVID-19 Vaccination: A Case Report.
    Rossetti A; Gheihman G; O'Hare M; Kosowsky JM
    J Emerg Med; 2021 Dec; 61(6):e141-e145. PubMed ID: 34538679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Guillain-Barrè syndrome triggered by SARS-CoV-2? Case report and literature review.
    Agosti E; Giorgianni A; D'Amore F; Vinacci G; Balbi S; Locatelli D
    Neurol Sci; 2021 Feb; 42(2):607-612. PubMed ID: 32643136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 as a trigger of Guillain-Barré syndrome: A review of the molecular mechanism.
    Malekpour M; Khanmohammadi S; Meybodi MJE; Shekouh D; Rahmanian MR; Kardeh S; Azarpira N
    Immun Inflamm Dis; 2023 May; 11(5):e875. PubMed ID: 37249286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases.
    Abu-Rumeileh S; Abdelhak A; Foschi M; Tumani H; Otto M
    J Neurol; 2021 Apr; 268(4):1133-1170. PubMed ID: 32840686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guillain-Barré Syndrome in a Child With COVID-19 Infection.
    Curtis M; Bhumbra S; Felker MV; Jordan BL; Kim J; Weber M; Friedman ML
    Pediatrics; 2021 Apr; 147(4):. PubMed ID: 33093141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two case reports and a literature review of typical GBS and rare GBS variants associated with COVID-19.
    Orak SA; Kubur ÇÇ; Atasever AK; Polat M
    Arch Pediatr; 2023 May; 30(4):236-239. PubMed ID: 37069023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 50-Year-Old Patient with Guillain-Barré Syndrome after COVID-19: A Case Report.
    Chmiela T; Rzepka M; Krzystanek E; Gorzkowska A
    Medicina (Kaunas); 2021 Jul; 57(8):. PubMed ID: 34440980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Report: Four cases of SARS-CoV-2-associated Guillain-Barré Syndrome with SARS-CoV-2-positive cerebrospinal fluid detected by metagenomic next-generation sequencing: a retrospective case series from China.
    Guan Y; Yu C; Fei Y; Wang Q; Wang P; Zuo W; Wu H; Qi X; Shi Q
    Front Immunol; 2023; 14():1258579. PubMed ID: 37701436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.